SEC Form 4 · accession 0001140361-17-042712
RESMED INC · RMD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
David Pendarvis
Officer — Chief Administrative Officer
Period of report
Nov 10, 2017
Accepted (ET)
Nov 14, 2017 · 3:55 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000943819
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| ResMed Common StockF1 | Nov 10, 2017 | F | 1,194 | $83.06 | D | 93,190 | D | |
| ResMed Common StockF2 | Nov 10, 2017 | F | 1,140 | $83.06 | D | 92,050 | D | |
| ResMed Common StockF3 | Nov 10, 2017 | F | 1,262 | $83.06 | D | 90,788 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Disposition to issuer for tax withholding on vesting of performance-based Restricted Stock Units granted on 11/19/2014.
- F2Disposition to issuer for tax withholding on vesting of performance-based Restricted Stock Units granted on 11/19/2015.
- F3Disposition to issuer for tax withholding on vesting of performance-based Restricted Stock Units granted on 11/16/2016.